immune system
• all mice inoculated with brain homogenates from Prnptm2(PRNP*129M)Tkit Tg(Prnp-PRNP*129M)1Tkit mice that succumb to sporadic Creutzfeldt-Jakob VV2 prion infection develop prion protein deposits in the spleen
|
• mice are not susceptible to bovine spongiform encephalopathy prion infection
(J:105882)
• incubation period following infection with sporadic Creutzfeldt-Jakob MM1 prions is 542 and 648 days for 2 mice compared to 467+/-24 days for Prnptm2(PRNP*129M)Tkit homozygotes
(J:126777)
• incubation period following infection with sporadic Creutzfeldt-Jakob VV2 prions is 312+/-7 days
(J:126777)
|
• incubation period following infection with plaque-type dura matter graft-associated Creutzfeldt-Jakob (patient KR and KD) prions is 259+/-6 days and 304+/-13 days compared to 420+/-10 days and 398+/-10 days, respectively, in Prnptm5(PRNP*129)Tkit/ Prnptm5(PRNP*129)Tkit Tg(Prnp-PRNP*)1Tkit mice
|
nervous system
• mice are more susceptible to infection with non-plaque-type dura matter graft-associated Creutzfeldt-Jakob and sporadic Creutzfeldt-Jakob VV2 than Prnptm2(PRNP*129M)Tkit homozygotes
• however, intraperitoneal injection of sporadic Creutzfeldt-Jakob VV2 did not produce prion protein deposits in the spleen
|
hematopoietic system
• all mice inoculated with brain homogenates from Prnptm2(PRNP*129M)Tkit Tg(Prnp-PRNP*129M)1Tkit mice that succumb to sporadic Creutzfeldt-Jakob VV2 prion infection develop prion protein deposits in the spleen
|